NO165145C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.

Info

Publication number
NO165145C
NO165145C NO890822A NO890822A NO165145C NO 165145 C NO165145 C NO 165145C NO 890822 A NO890822 A NO 890822A NO 890822 A NO890822 A NO 890822A NO 165145 C NO165145 C NO 165145C
Authority
NO
Norway
Prior art keywords
imidazo
kinolin
preparation
carbon atoms
amine derivatives
Prior art date
Application number
NO890822A
Other languages
English (en)
Other versions
NO890822D0 (no
NO890822L (no
NO165145B (no
Inventor
John Franklin Gerster
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO890822L publication Critical patent/NO890822L/no
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Priority to NO890822A priority Critical patent/NO165145C/no
Publication of NO890822D0 publication Critical patent/NO890822D0/no
Publication of NO165145B publication Critical patent/NO165145B/no
Publication of NO165145C publication Critical patent/NO165145C/no
Priority to NO1999015C priority patent/NO1999015I1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Physical Water Treatments (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Alarm Systems (AREA)
  • Quinoline Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Lubricants (AREA)
NO890822A 1983-11-18 1989-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater. NO165145C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO890822A NO165145C (no) 1983-11-18 1989-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.
NO1999015C NO1999015I1 (no) 1983-11-18 1999-07-08 Imiquimod

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55315883A 1983-11-18 1983-11-18
US55315783A 1983-11-18 1983-11-18
NO844565A NO163819C (no) 1983-11-18 1984-11-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.
NO890822A NO165145C (no) 1983-11-18 1989-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.

Publications (4)

Publication Number Publication Date
NO890822L NO890822L (no) 1985-05-20
NO890822D0 NO890822D0 (no) 1989-02-27
NO165145B NO165145B (no) 1990-09-24
NO165145C true NO165145C (no) 1991-01-02

Family

ID=27070262

Family Applications (7)

Application Number Title Priority Date Filing Date
NO844565A NO163819C (no) 1983-11-18 1984-11-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.
NO890826A NO168705C (no) 1983-11-18 1989-02-27 3-nitro-kinoliner.
NO890822A NO165145C (no) 1983-11-18 1989-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.
NO890823A NO165146C (no) 1983-11-18 1989-02-27 1h-imidazo-(4,5-c)-kinolin-4-klorforbindelser.
NO890825A NO169437C (no) 1983-11-18 1989-02-27 3-amino-kinoliner.
NO890824A NO165147C (no) 1983-11-18 1989-02-27 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser.
NO1999015C NO1999015I1 (no) 1983-11-18 1999-07-08 Imiquimod

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO844565A NO163819C (no) 1983-11-18 1984-11-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.
NO890826A NO168705C (no) 1983-11-18 1989-02-27 3-nitro-kinoliner.

Family Applications After (4)

Application Number Title Priority Date Filing Date
NO890823A NO165146C (no) 1983-11-18 1989-02-27 1h-imidazo-(4,5-c)-kinolin-4-klorforbindelser.
NO890825A NO169437C (no) 1983-11-18 1989-02-27 3-amino-kinoliner.
NO890824A NO165147C (no) 1983-11-18 1989-02-27 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser.
NO1999015C NO1999015I1 (no) 1983-11-18 1999-07-08 Imiquimod

Country Status (15)

Country Link
EP (2) EP0310950B1 (no)
JP (1) JPS60123488A (no)
KR (1) KR900005657B1 (no)
AT (2) ATE49763T1 (no)
AU (2) AU581190B2 (no)
CA (1) CA1271477A (no)
DE (3) DE3486043T2 (no)
DK (6) DK164280C (no)
ES (1) ES8603477A1 (no)
IE (1) IE57874B1 (no)
IL (2) IL84537A (no)
NL (2) NL980043I1 (no)
NO (7) NO163819C (no)
NZ (1) NZ210228A (no)
PH (1) PH22338A (no)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US4942168A (en) * 1987-07-13 1990-07-17 Hoechst-Roussel Pharmaceuticals Inc. Hydroxyquinoline amines, and method of enhancing memory in mammals
CA1335996C (en) * 1988-02-16 1995-06-20 Susumu Takada 2-substituted carbonylimidazo¬4,5-c|quinolines
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
DK0385630T3 (da) * 1989-02-27 1997-05-12 Riker Laboratories Inc 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler
US4994468A (en) * 1989-03-07 1991-02-19 Kyowa Hakko Kogyo Co., Ltd. Imidazoquinolone derivatives
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
CA2021338C (en) * 1989-07-18 1996-07-16 Fumio Suzuki Imidazoquinolone derivatives
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
FR2654021B1 (fr) * 1989-11-07 1992-02-28 Simond Jacques Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
GB8928281D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
EP0459505B1 (en) * 1990-06-01 1996-10-02 Kyowa Hakko Kogyo Co., Ltd. Imidazonaphthyridine derivatives
UA32546C2 (uk) * 1991-03-01 2001-02-15 Міннесота Майнінг Енд Мен'Юфекчурінг Компані 1,2-заміщені 1н-імідазо[4,5-с]хінолін-4-аміни, проміжні сполуки для їх синтезу, антивірусна фармацевтична композиція, спосіб лікування інфікованих ссавців, спосіб індукування біосинтезу інтерферону у ссавців, спосіб уповільнення росту бластом
US5266575A (en) * 1991-11-06 1993-11-30 Minnesota Mining And Manufacturing Company 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5395937A (en) * 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5693811A (en) * 1996-06-21 1997-12-02 Minnesota Mining And Manufacturing Company Process for preparing tetrahdroimidazoquinolinamines
EP0894797A4 (en) * 1997-01-09 2001-08-16 Terumo Corp NEW AMID DERIVATIVES AND INTERMEDIATES ON YOUR SYNTHESIS
JPH10298181A (ja) * 1997-04-25 1998-11-10 Sumitomo Pharmaceut Co Ltd タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤
JP2000119271A (ja) * 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd １ｈ―イミダゾピリジン誘導体
ES2393186T3 (es) * 2001-10-23 2012-12-19 Merck Serono Sa Derivados de azol y composiciones farmacéuticas que los contienen
GB0211649D0 (en) * 2002-05-21 2002-07-03 Novartis Ag Organic compounds
PT1543002E (pt) 2002-07-23 2006-11-30 Teva Gyogyszergyar Zartkoeruen Preparação de intermediários 1h-imidazo ( 4,5-c )quinolin-4-aminas via 1h- imidazo (4,5-c ) quinolina-4-ftalimida
PT1539752E (pt) 2002-07-26 2007-05-31 Teva Gyogyszergyar Zartkoeruen Preparação de 1h-imidazo [4,5-c] quinolina-4-aminas via novos intermediários imidazo [4,5-c] quinolina-4-ciano e 1h-imidazo [4,5-c] quinolina-4-carboxamida
EP1653914A4 (en) 2003-08-12 2008-10-29 3M Innovative Properties Co COMPOUNDS CONTAINING OXIME SUBSTITUTED IMIDAZO STRUCTURE
MXPA06002199A (es) 2003-08-27 2006-05-22 3M Innovative Properties Co Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi.
JP2007504269A (ja) 2003-09-05 2007-03-01 スリーエム イノベイティブ プロパティズ カンパニー Ｃｄ５＋ｂ細胞リンパ腫の治療方法
US7687628B2 (en) 2003-10-01 2010-03-30 Taro Pharmaceuticals U.S.A., Inc. Method of preparing 4-amino-1H-imidazo(4,5-c)quinolines and acid addition salts thereof
AU2004278014B2 (en) 2003-10-03 2011-04-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
ITMI20032121A1 (it) * 2003-11-04 2005-05-05 Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm Procedimento per la preparazione di imiquimod e suoi intermedi
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
CN1906192A (zh) 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
MXPA06005910A (es) 2003-11-25 2006-08-23 3M Innovative Properties Co Sistemas de anillo imidazo sustituido y metodos.
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
CA2594674C (en) 2004-12-30 2016-05-17 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
EP1931352B1 (en) 2005-08-22 2016-04-13 The Regents of The University of California Tlr agonists
EP2029597A4 (en) 2006-05-31 2011-11-23 Univ California purine analogs
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
PL2510946T3 (pl) 2007-02-07 2015-12-31 Univ California Koniugaty syntetycznych agonistów tlr i ich zastosowania
EP2009002A1 (en) * 2007-06-21 2008-12-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
BRPI1008383A2 (pt) 2009-02-11 2016-02-23 Univ California composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto
ES2943385T3 (es) 2010-08-17 2023-06-12 3M Innovative Properties Company Compuesto modificador de la respuesta inmunitaria lipidada y su uso médico
US8728486B2 (en) 2011-05-18 2014-05-20 University Of Kansas Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
CA2850932A1 (en) 2011-10-04 2013-04-11 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
MX369611B (es) * 2013-02-01 2019-11-14 Wellstat Therapeutics Corp Compuestos de amina que tienen actividad anti-inflamatoria, antifungica, antiparasitaria y anticancer.
KR20150127085A (ko) * 2013-03-15 2015-11-16 신젠타 파티서페이션즈 아게 살균 활성인 이미다조피리딘 유도체
ES2538880B1 (es) * 2013-12-24 2016-09-08 Laboratorios Viñas S.A. Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
EP3092255A4 (en) 2014-01-10 2017-09-20 Birdie Biopharmaceuticals Inc. Compounds and compositions for treating egfr expressing tumors
JP6760919B2 (ja) 2014-07-09 2020-09-23 バーディー バイオファーマシューティカルズ インコーポレイテッド 腫瘍を治療するための抗ｐｄ−ｌ１組み合わせ
WO2017046675A1 (en) * 2015-09-14 2017-03-23 Pfizer Inc. Novel imidazo [4,5-c] quinoline and imidazo [4,5-c][1,5] naphthyridine derivatives as lrrk2 inhibitors
CN106943596A (zh) 2016-01-07 2017-07-14 博笛生物科技（北京）有限公司 用于***的抗-cd20组合
CN106943597A (zh) 2016-01-07 2017-07-14 博笛生物科技（北京）有限公司 用于***的抗-egfr组合
WO2017184735A1 (en) * 2016-04-19 2017-10-26 Ifm Therapeutics, Inc Nlrp3 modulators
JP7104633B6 (ja) 2016-04-19 2023-12-22 イネイト・テューマー・イミュニティ・インコーポレイテッド Ｎｌｒｐ３修飾因子
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
TWI674261B (zh) 2017-02-17 2019-10-11 美商英能腫瘤免疫股份有限公司 Nlrp3 調節劑
CN108794467A (zh) 2017-04-27 2018-11-13 博笛生物科技有限公司 2-氨基-喹啉衍生物
WO2018232725A1 (en) 2017-06-23 2018-12-27 Birdie Biopharmaceuticals, Inc. PHARMACEUTICAL COMPOSITIONS
FR3113287B1 (fr) 2020-08-07 2023-06-23 Phv Pharma Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700674A (en) * 1969-04-30 1972-10-24 American Cyanamid Co 4-alkylamino-3-nitroquinolines
IL68495A0 (en) * 1982-05-03 1983-07-31 Lilly Co Eli 2-phenylimidazo(4,5-c)pyridines

Also Published As

Publication number Publication date
IE842952L (en) 1985-05-18
DK135991D0 (da) 1991-07-16
DK135791D0 (da) 1991-07-16
ATE49763T1 (de) 1990-02-15
ES537677A0 (es) 1985-12-16
DE3486043D1 (de) 1993-02-25
NO169437C (no) 1992-06-24
DK164452B (da) 1992-06-29
DK136191A (da) 1991-07-16
AU3540284A (en) 1985-05-23
DK164451B (da) 1992-06-29
NO890822D0 (no) 1989-02-27
NO890822L (no) 1985-05-20
NO165147B (no) 1990-09-24
NO890823D0 (no) 1989-02-27
DE3486043T2 (de) 1993-06-03
NO165146B (no) 1990-09-24
IL84537A0 (en) 1988-04-29
KR900005657B1 (ko) 1990-08-03
KR850003890A (ko) 1985-06-29
ATE84525T1 (de) 1993-01-15
DK135891D0 (da) 1991-07-16
EP0145340A3 (en) 1986-06-11
NL980041I1 (nl) 1999-02-01
NL980041I2 (nl) 1999-07-01
NO1999015I1 (no) 1999-07-08
AU581190B2 (en) 1989-02-16
DE3481124D1 (de) 1990-03-01
ES8603477A1 (es) 1985-12-16
DK169179B1 (da) 1994-09-05
NO890825L (no) 1985-05-20
DK164451C (da) 1992-11-09
NO844565L (no) 1985-05-20
EP0145340A2 (en) 1985-06-19
NO890824D0 (no) 1989-02-27
JPS60123488A (ja) 1985-07-02
NO890826D0 (no) 1989-02-27
DK136091A (da) 1991-07-16
DK164280B (da) 1992-06-01
DK165921C (da) 1993-06-28
DK542684D0 (da) 1984-11-15
DK164455C (da) 1992-11-16
DK135791A (da) 1991-07-16
EP0310950B1 (en) 1993-01-13
DK136091D0 (da) 1991-07-16
NO890824L (no) 1985-05-20
IE57874B1 (en) 1993-05-05
PH22338A (en) 1988-08-12
DK164455B (da) 1992-06-29
AU611997B2 (en) 1991-06-27
EP0145340B1 (en) 1990-01-24
DK164280C (da) 1992-11-30
NO890823L (no) 1985-05-20
DK165921B (da) 1993-02-08
NO890825D0 (no) 1989-02-27
DK136191D0 (da) 1991-07-16
DE19975027I2 (de) 2000-09-21
NL980043I1 (nl) 1999-02-01
NZ210228A (en) 1989-01-27
CA1271477A (en) 1990-07-10
EP0310950A1 (en) 1989-04-12
DK135991A (da) 1991-07-16
DK135891A (da) 1991-07-16
NO165145B (no) 1990-09-24
NO163819B (no) 1990-04-17
DK542684A (da) 1985-05-19
NO890826L (no) 1985-05-20
NO168705C (no) 1992-03-25
NO168705B (no) 1991-12-16
DK164452C (da) 1992-11-09
AU2991189A (en) 1989-06-15
NO169437B (no) 1992-03-16
NO163819C (no) 1990-08-01
NO165146C (no) 1991-01-02
JPH0586391B2 (no) 1993-12-10
IL84537A (en) 1990-12-23
NO165147C (no) 1991-01-02

Similar Documents

Publication Publication Date Title
NO165145C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees